Jingxin Pharm was established in 1974 and is an integrated company covering manufacturing, R & D and marketing center. The products cover from API to Finished Product, more than 160 products have been approved. It is one the biggest manufacturing base for the APIs of quinolones and occupied a relatively large market share for the product named Ciprofloxacin Hydrochloride and the Levofloxacin Hydrochloride.